📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
ACE Approves Joint Venture with Japan's KATO Works for Heavy Crane Manufacturing
Action Construction Equipment (ACE) has approved a strategic Joint Venture with Japan-based KATO WORKS CO., LTD. to manufacture heavy cranes, including Truck, Crawler, and Rough Terrain types. This collaboration combines KATO's global engineering expertise with ACE's extensive Indian manufacturing base and sales network of over 125 locations. The move is designed to enhance product competitiveness and cost efficiency while targeting growth in both domestic and international markets. ACE currently exports to 37 countries, and this partnership is expected to significantly strengthen its high-end equipment portfolio.
Key Highlights
Strategic partnership with KATO WORKS CO., LTD., Japan, for technology and design expertise.
Focus on manufacturing high-value Heavy Cranes: Truck, Crawler, and Rough Terrain types.
Leverages ACE's existing domestic network of 125+ locations and 13 regional offices.
Targets expansion across ACE's current international footprint of 37+ export countries.
Board has authorized management to finalize definitive agreements and incorporate the JV entity.
💼 Action for Investors
This is a major strategic positive that moves ACE up the value chain into high-tonnage equipment. Investors should maintain a positive outlook and watch for further disclosures regarding the specific investment outlay and equity structure of the JV.
Panacea Biotec Q3 Results: Consolidated Net Profit at ₹389 Lakh; Standalone Loss Widens
Panacea Biotec reported a consolidated net profit of ₹389 lakh for the quarter ended December 31, 2025, a slight decline from ₹444 lakh in the previous year. Consolidated revenue from operations grew marginally to ₹16,519 lakh compared to ₹16,349 lakh YoY. However, the standalone business faced significant pressure, reporting a net loss of ₹736 lakh against a profit of ₹965 lakh in the same period last year. The company continues to benefit from exceptional income, including a ₹858 lakh settlement with Apotex Inc. and deferred consideration from previous brand sales.
Key Highlights
Consolidated revenue from operations increased 1.04% YoY to ₹16,519 lakh.
Formulations segment EBIT turned positive at ₹906 lakh compared to a loss of ₹758 lakh in Q3 FY25.
Vaccines segment reported a loss of ₹257 lakh at the EBIT level for the quarter.
Exceptional income of ₹1,679 lakh recognized in 9M FY26, including ₹858 lakh from a settlement with Apotex Inc.
Standalone net loss for 9M FY26 widened significantly to ₹2,970 lakh from ₹284 lakh in 9M FY25.
💼 Action for Investors
Investors should exercise caution as the company remains loss-making on a 9-month consolidated basis despite the quarterly profit. Monitor the vaccines segment's recovery and the company's ability to generate consistent operational cash flow without relying on exceptional items.
Panacea Biotec Q3 FY26 Results: Consolidated Net Profit at ₹3.89 Cr; Revenue Grows 1% YoY
Panacea Biotec reported a consolidated net profit of ₹3.89 crore for Q3 FY26, a slight decline from ₹4.44 crore in the same quarter last year. Consolidated revenue from operations grew marginally by 1% YoY to ₹165.19 crore. For the nine-month period, the company remains in a net loss of ₹6.16 crore, though this narrowed from a loss of ₹6.73 crore in the previous year. The results were significantly supported by an exceptional income of ₹16.79 crore in the 9M period, including a settlement with Apotex Inc.
Key Highlights
Consolidated Q3 revenue reached ₹165.19 crore, a marginal 1% increase over the previous year's ₹163.49 crore.
Formulations segment profit improved significantly to ₹9.06 crore from a loss of ₹7.58 crore in Q3 FY25.
Vaccines segment reported a loss of ₹2.57 crore for the quarter despite revenue of ₹99.24 crore.
Exceptional income of ₹16.79 crore for 9M FY26 includes ₹8.58 crore from a settlement with Apotex Inc.
Standalone net loss stood at ₹7.36 crore for Q3 FY26, compared to a profit of ₹9.65 crore in Q3 FY25.
💼 Action for Investors
Investors should monitor the company's ability to sustain operational profitability without relying on exceptional items and brand sale deferrals. While the turnaround in the formulations segment is positive, the core vaccine business remains under pressure.
Pace Digitek Secures Rs. 17,750 Million Solar + BESS Project; Order Book Crosses Rs. 100 Billion
Pace Digitek Limited has secured a massive Rs. 17,750 million order from KREDL for a 250 MW Solar and 1.1 GWh Battery Energy Storage System (BESS) project in Karnataka. This win pushes the company's total consolidated order book to over Rs. 102,428 million, with the energy segment contributing nearly 76% of the total. The project features an interim tariff of Rs. 5.51 per unit and is expected to be completed within 18 months. This contract significantly strengthens the company's position in the high-growth BESS market, where its total portfolio now exceeds 5 GWh.
Key Highlights
Secured a Letter of Award worth Rs. 17,750 million for a 250 MW Solar + 1.1 GWh BESS project
Total consolidated order book reaches Rs. 102,428 million, with Rs. 77,792 million in the Energy segment
Project timeline for Commercial Operation Date (COD) is 18 months from PPA signing
Interim tariff set at Rs. 5.51 per unit with Viability Gap Funding (VGF) for a 25-year tenure
Total BESS order book portfolio now exceeds 5 GWh, highlighting leadership in energy storage
💼 Action for Investors
Investors should view this as a strong growth signal, given the massive order book visibility and the company's focus on the high-margin BESS segment. Monitor the execution timeline over the next 18 months to ensure project milestones are met.
Pace Digitek Secures Rs 17,750 Million Solar and BESS Project from KREDL
Pace Digitek Limited has been awarded a major contract by Karnataka Renewable Energy Development Limited (KREDL) valued at approximately Rs 17,750 million. The project entails the development of a 250 MWAC Solar PV plant along with a 250 MW/1100 MWh Battery Energy Storage System (BESS) at Pavagada Solar Park. The project is to be executed within 18 months of signing the PPA and includes a 25-year operation period. The power will be supplied at a tariff of Rs 5.51 per unit, ensuring long-term revenue stability.
Key Highlights
Total project cost estimated at Rs 17,750 million including GST
Includes 250 MWAC Solar PV and 250 MW/1100 MWh Battery Energy Storage System
Execution timeline of 18 months from PPA signing
Tariff fixed at Rs 5.51 per unit for a 25-year operational period
💼 Action for Investors
This massive order provides significant revenue visibility and marks a major milestone in the company's growth in the renewable energy sector. Investors should monitor the company's execution progress over the next 18 months and the subsequent impact on its balance sheet.
Ace Integrated Solutions Q3 Revenue Drops 92% YoY; Reports Net Loss of ₹27 Lakhs
Ace Integrated Solutions Limited reported a severe decline in performance for Q3 FY26, with revenue from operations falling to just ₹11 Lakhs from ₹143 Lakhs YoY. The company recorded a net loss of ₹27 Lakhs for the quarter, compared to a loss of ₹21 Lakhs in the previous year's corresponding quarter. For the nine-month period ended December 2025, total income stood at ₹118 Lakhs, down from ₹729 Lakhs in the previous year. Notably, the company's core segments like Examination and Printing reported zero revenue, with the only activity coming from Speciality Chemicals and a new Property services segment.
Key Highlights
Revenue from operations plummeted 92.3% YoY to ₹11 Lakhs in Q3 FY26.
Net loss for the quarter widened to ₹27 Lakhs from ₹21 Lakhs in the same period last year.
Nine-month revenue fell to ₹118 Lakhs from ₹711 Lakhs, reflecting a massive business slowdown.
Core segments (Examination and Printing) generated zero revenue during the quarter.
Recognized an exceptional loss of ₹2.39 Lakhs due to the impact of New Labour Codes.
💼 Action for Investors
The company's financial health is deteriorating with a near-total collapse of its primary revenue streams. Investors should exercise high caution and monitor if the new property segment can gain significant traction before considering any position.
Pace Digitek Q3 FY26: PAT Up 11.3% YoY to ₹788 Mn; Order Book Reaches ₹84,678 Mn
Pace Digitek reported a steady Q3 FY26 with revenue growing 13.5% YoY to ₹6,440 million and PAT increasing 11.3% YoY to ₹788 million. While EBITDA margins contracted to 18.3% from 21.4% YoY due to inter-company profit eliminations, the company saw strong sequential revenue growth of 20.7%. The order book remains robust at ₹84,678 million, providing multi-year revenue visibility. Furthermore, the company is aggressively expanding its BESS manufacturing capacity, targeting 10 GWh by Q4 FY2027.
Key Highlights
Revenue from operations grew 13.5% YoY to ₹6,440 million in Q3 FY26.
Profit After Tax (PAT) increased by 11.3% YoY to ₹788 million with a 12.2% margin.
Total order book stands at a significant ₹84,678 million as of January 31, 2026.
Secured new order inflows of ₹31,287 million post-Q2 FY26 across Energy and Telecom segments.
BESS manufacturing capacity expansion to 10 GWh is on track, with 2.5 GWh addition expected by Q4 FY26.
💼 Action for Investors
Investors should take note of the massive order book which provides high revenue visibility; the key will be the timely execution of BESS capacity expansions. Monitor if the EBITDA margins recover as the company scales its backward integration initiatives.
Ambuja Cements Receives NCLT Sanction for Merger with Sanghi Industries
The National Company Law Tribunal (NCLT), Ahmedabad Bench, has officially sanctioned the Scheme of Arrangement for the merger of Sanghi Industries Limited into Ambuja Cements. This regulatory approval marks a significant step in Ambuja Cements' expansion strategy, following its acquisition of a majority stake in Sanghi Industries. The merger is set with a retrospective appointed date of April 1, 2024. This integration is expected to provide Ambuja Cements with substantial operational synergies and a stronger market presence in Western India.
Key Highlights
NCLT Ahmedabad sanctioned the merger scheme on February 9, 2026.
The Appointed Date for the Scheme of Arrangement is April 1, 2024.
Sanghi Industries Limited will be the Transferor Company into Ambuja Cements Limited.
The merger remains subject to final procedural steps before becoming fully effective.
The consolidation aims to leverage Sanghi's low-cost clinker production and coastal logistics.
💼 Action for Investors
Investors should maintain a positive outlook as the merger formalization will lead to better financial consolidation and operational efficiencies. Monitor for the official 'Effective Date' announcement which will trigger the final integration process.
ACE Q3 FY26 PAT Grows 8.15% to ₹115.88 Cr; EBITDA Margins Expand to 18.5%
Action Construction Equipment (ACE) reported a flattish Q3 FY26 revenue of ₹888 crores, but achieved an 8.15% YoY growth in PAT to ₹115.88 crores. EBITDA margins expanded by 74 basis points to 18.5%, driven by operational efficiencies despite a subdued first half of the year. The company noted a recovery in demand following the transition to CEV V emission norms and remains optimistic about the government's ₹12.21 lakh crore capex budget for FY27. Management expects a flattish top-line for the full year but with improved profitability compared to the previous year.
Key Highlights
Q3 FY26 PAT grew 8.15% YoY to ₹115.88 crores with margins at 13.04%
EBITDA increased 2.48% to ₹164 crores, with margins expanding 74 bps to 18.5%
9M FY26 PAT rose 11% YoY to ₹316 crores despite a 3.21% decline in total income
Crane and Construction segment contributed 90% of revenue at ₹763 crores for the quarter
Management expects flattish revenue for FY26 but with a better margin profile than FY25
💼 Action for Investors
Investors should monitor the notification of anti-dumping duties on Chinese cranes and the execution of government telehandler orders. The stock remains a strong play on India's infrastructure cycle given the margin resilience.
Pace Digitek Q3 Revenue Up 13.5% YoY to ₹6,440 Mn; Order Book Hits ₹84,678 Mn
Pace Digitek Limited reported a strong Q3 FY2026 with consolidated revenue rising 13.5% YoY to ₹6,440 Mn and Profit After Tax (PAT) increasing 11.3% to ₹788 Mn. The company's total order book has reached a significant ₹84,678 Mn as of January 31, 2026, supported by ₹31,287 Mn in new order wins post-Q2. The Energy vertical is emerging as a primary driver, holding ₹60,042 Mn of the order book, with a strategic shift toward high-value Build-Own-Operate (BOO) projects. Additionally, the company is aggressively expanding its BESS manufacturing capacity from 2.5 GWh to 10 GWh to capitalize on India's energy transition.
Key Highlights
Consolidated revenue grew 13.5% YoY to ₹6,440 Mn; Standalone PAT surged 39.1% YoY to ₹933 Mn.
Total order book stands at ₹84,678 Mn, with the Energy vertical contributing ₹60,042 Mn (71% of total).
Secured major BOO projects from MSEDCL (₹18,500 Mn) and SECI (₹7,000 Mn) for BESS and Solar.
BESS manufacturing capacity expansion from 2.5 GWh to 10 GWh is currently in progress at the Bidadi facility.
Operational milestones include 1,891 km of OFC deployed and 428 new telecom towers erected in Q3 FY26.
💼 Action for Investors
Investors should focus on the company's successful pivot into the high-growth BESS and renewable energy sectors, backed by a massive order book. Monitor the execution timelines of the BOO projects and the commissioning of the 10 GWh manufacturing capacity as these will be the primary catalysts for future margin expansion.
Pace Digitek Q3 FY26 Revenue Jumps 83% YoY to ₹81.44 Cr; PAT Declines to ₹3.27 Cr
Pace Digitek Limited reported a strong top-line performance for Q3 FY26, with revenue from operations surging 83% year-on-year to ₹81.44 crore. However, net profit for the quarter faced pressure, declining to ₹3.27 crore from ₹5.08 crore in the same period last year, primarily due to a significant rise in operational expenses and finance costs. For the nine-month period ended December 31, 2025, the company maintained a steady PAT of ₹12.42 crore. The results highlight a period of rapid scale-up in operations but with compressed margins.
Key Highlights
Revenue from operations grew 83% YoY to ₹81.44 crore in Q3 FY26.
Net Profit (PAT) for the quarter fell 35.5% YoY to ₹3.27 crore.
Total expenses for the quarter increased to ₹77.03 crore compared to ₹37.73 crore in Q3 FY25.
Nine-month revenue reached ₹231.00 crore, a significant jump from ₹133.33 crore in the previous year.
Basic and Diluted EPS for the quarter stood at ₹0.73, down from ₹1.25 in the preceding quarter.
💼 Action for Investors
While the massive revenue growth indicates strong market demand and expansion, the decline in profitability is a concern. Investors should monitor the company's ability to manage rising procurement and finance costs in upcoming quarters.
UltraTech Commissions 2.7 MTPA Grinding Capacity in Aligarh, UP
UltraTech Cement has successfully commissioned an additional 2.7 mtpa grinding capacity at its Aligarh unit in Uttar Pradesh. This expansion increases the Aligarh unit's total capacity to 4.0 mtpa and the company's total footprint in Uttar Pradesh to 13.1 mtpa. Following this commissioning, UltraTech's total domestic grey cement capacity stands at 191.36 mtpa, with a global capacity of 196.76 mtpa. This move is part of the company's strategy to strengthen its presence in high-growth markets and optimize logistics.
Key Highlights
Commissioned 2.7 mtpa additional grinding capacity at the Aligarh unit in Uttar Pradesh.
Total domestic grey cement manufacturing capacity reaches 191.36 mtpa.
Global manufacturing capacity, including overseas operations, now stands at 196.76 mtpa.
Total capacity in the state of Uttar Pradesh increased to 13.1 mtpa.
Expansion aimed at improving market reach and logistics optimization in high-growth regions.
💼 Action for Investors
Investors should view this as a positive development that reinforces UltraTech's market leadership and capacity to meet rising demand. Monitor the company's progress toward its goal of reaching 200 mtpa capacity.
Panacea Biotec's Baddi Facility Receives GMP Non-Compliance From Hungary Regulator
Panacea Biotec's subsidiary facility in Baddi has received a 'Statement of non-compliance' with Good Manufacturing Practices (GMP) from Hungary's NCPHP, resulting in the revocation of its GMP certificates. The regulator has proposed halting supplies of non-vital products to the EU market, though no quality risks were found in products already released. The financial impact is expected to be minimal as the EU market contributed only 0.32% of the company's total consolidated net revenues in FY 2024-25. The company is currently implementing corrective and preventive actions (CAPA) to seek a re-inspection and restore compliance.
Key Highlights
NCPHP Hungary issued a Statement of non-compliance with GMP for the Baddi facility on February 03, 2026.
All valid GMP certificates issued by NCPHP for the facility have been revoked following the inspection.
Revenue from the European Union market accounted for only 0.32% of consolidated net revenues in FY 2024-25.
No quality risks were observed by regulators for products already released into the market.
Company is implementing CAPA and will request a re-inspection at the earliest to restore certificates.
💼 Action for Investors
Investors should note that while the immediate revenue impact is negligible at 0.32%, the regulatory failure at a major facility is a sentiment negative. Monitor the timeline for CAPA implementation and successful re-inspection to ensure no broader compliance issues exist.
UltraTech Cement Targets 194 MTPA Capacity by 2028; FY25 Revenue Hits $8.9 Billion
UltraTech Cement has released an updated corporate dossier outlining its path to becoming a 194.06 MTPA capacity player by 2028. As of December 2025, the company maintains a market capitalization of approximately USD 38.6 billion and reported FY25 consolidated revenues of USD 8.9 billion. The growth strategy relies on significant inorganic expansions, including the acquisitions of India Cements (14.45 MTPA) and Kesoram (10.75 MTPA). Additionally, its Ready Mix Concrete (RMC) business has scaled to 425 plants, contributing Rs 6,170 crore in revenue during FY25.
Key Highlights
Targeting a total cement capacity of 194.06 MTPA by 2028 through organic and inorganic routes.
Consolidated revenue for FY25 reached approximately USD 8.9 billion with 2.7 billion bags of cement sold annually.
RMC segment revenue stood at Rs 6,170 crore in FY25, supported by a network of 425 plants.
Retail footprint expanded to 5,290 UltraTech Building Solutions outlets across 23 Indian states.
Major recent acquisitions include India Cements (14.45 MTPA) and Kesoram (10.75 MTPA) to solidify market leadership.
💼 Action for Investors
Investors should maintain a positive outlook on UltraTech as it consolidates its leadership through aggressive capacity additions and diversification into high-margin building products. Monitor the execution of the 194 MTPA roadmap and the integration of the India Cements acquisition for potential synergy benefits.
Ambuja Cements Targets 155 MTPA Capacity by 2028; Highlights 7.4% India GDP Growth Outlook
Ambuja Cements is aggressively scaling its operations, targeting a capacity of 155 MTPA by March 2028, up from 109 MTPA in December 2025. The company is leveraging the Adani Group's integrated infrastructure ecosystem to drive cost synergies in logistics, energy, and digital platforms. With India's GDP projected to grow at 7.4% in FY26 and cement demand expected to rise by 8%, Ambuja is positioning itself as a primary beneficiary of the national infrastructure super-cycle. The company also maintains a strong ESG focus, being the first Indian cement firm to adopt the TNFD framework for nature-positive disclosures.
Key Highlights
Capacity expansion roadmap: 109 MTPA as of Dec 2025, targeting 155 MTPA by March 2028 exit.
India's real GDP growth estimated at 7.4% for FY26 with cement demand projected to grow at ~8%.
Government infrastructure capex allocation of $130 Billion for FY26 to act as a major demand driver.
World's 9th largest cement company with science-based net-zero targets validated by SBTi for 2030 and 2050.
Operational synergies with Adani Portfolio across ports, power, and logistics to enhance cost efficiency.
💼 Action for Investors
Investors should focus on the company's ability to execute its massive capacity expansion to 155 MTPA and the resulting margin improvements from Adani Group synergies. The stock remains a key long-term play on India's infrastructure and urbanization growth.
Ambuja Cements Q3 FY'26: Volume Up 17%, Normalized EBITDA Jumps 53% to ₹1,353 Cr
Ambuja Cements delivered a robust Q3 FY'26 performance, with sales volumes growing 17% YoY to 18.9 million tons, doubling the industry average. Normalized operating EBITDA rose 53% to ₹1,353 crores, while PAT surged 258% on a comparable basis to ₹378 crores. The company successfully reached a capacity of 109 MTPA and is aggressively targeting 155 MTPA by March 2028. Management highlighted that despite temporary cost spikes in the quarter, the December exit cost was below ₹4,000 per ton, indicating improving operational efficiency.
Key Highlights
Highest ever quarterly sales volume of 18.9 million tons, representing a 16.6% market share.
Normalized EBITDA per ton increased by 31% YoY to ₹718 per ton.
Premium cement volumes grew 31% YoY, now accounting for 35% of total trade sales.
Commissioned 2.4 MTPA Marwar Grinding Unit, bringing total capacity to 109 MTPA.
Green power share increased to 37%, with renewable energy footprint reaching 900 MW.
💼 Action for Investors
Investors should focus on the company's industry-leading volume growth and aggressive capacity expansion roadmap towards 155 MTPA. The successful integration of acquired assets and the shift toward green energy provide a strong outlook for margin expansion in upcoming quarters.
Ambuja Cements Q3 FY26: Sales Volume Up 17% to 18.9 MT; EBITDA Grows 53% to ₹1,353 Cr
Ambuja Cements reported a robust Q3 FY26 with record quarterly sales volumes of 18.9 million tons, growing at twice the industry average. Normalized operating EBITDA rose 53% YoY to ₹1,353 crores, while PAT surged 258% to ₹378 crores on an adjusted basis. The company successfully commissioned the 2.4 MTPA Marwar Grinding Unit, bringing total capacity to 109 MTPA. Management remains focused on cost leadership, targeting a cost of ₹3,650 per ton by March 2028 through renewable energy and operational efficiencies.
Key Highlights
Highest ever quarterly sales volume of 18.9 million tons, up 17% YoY, with market share reaching 16.6%.
Normalized Operating EBITDA increased 53% YoY to ₹1,353 crores, with EBITDA per ton at ₹718.
Total capacity reached 109 MTPA following the early commissioning of the 2.4 MTPA Marwar Grinding Unit.
Renewable energy footprint expanded to 900 MW, contributing to a 15% reduction in power costs YoY.
Premium cement volumes grew 31% YoY, now accounting for 35% of total trade sales.
💼 Action for Investors
Investors should note the company's aggressive capacity expansion target of 155 MTPA by 2028 and the ongoing integration of ACC and Orient Cement. The focus on premiumization and cost reduction through green energy makes it a strong long-term play in the cement sector.
ACE Q3 FY26: PAT Up 4.2% to ₹116 Cr; EBITDA Margins Expand to 18.6%
Action Construction Equipment (ACE) reported a resilient Q3 FY26 with PAT growing 4.2% YoY to ₹1,164 million, despite a marginal 1.6% decline in total income to ₹8,904 million. The revenue dip reflects a high base effect from the previous year's pre-buying due to emission norm changes, but the company showed a strong 15.1% sequential recovery. EBITDA margins expanded to 18.59%, supported by a favorable product mix and cost-saving initiatives. Management remains optimistic citing the new Enhancement of Construction and Infrastructure Equipment scheme in the Union Budget.
Key Highlights
PAT increased 4.2% YoY to ₹1,164 million with PAT margins improving by 73 bps to 13.07%.
EBITDA margins expanded to 18.59% driven by favorable product mix and deepening cost efficiencies.
Total Income showed a strong sequential recovery of 15.1% QoQ, signaling market normalization after emission norm transitions.
Maintains dominant market leadership with 63% share in mobile cranes and 60% in tower cranes.
Launched new high-tech products including AI-integrated safety systems and India's first clutch-less transmission cranes.
💼 Action for Investors
Investors should focus on the company's margin expansion and strong sequential volume recovery as indicators of long-term health. ACE remains a primary beneficiary of India's accelerating infrastructure and manufacturing capex cycle.
Ambuja Cements MD Ajay Kapur Steps Down Effective January 31, 2026
Ambuja Cements has formally submitted the resignation letter of Mr. Ajay Kapur (DIN: 03096416), who stepped down as Managing Director. The resignation was effective from the close of business hours on January 31, 2026, following his superannuation. This update follows the company's initial intimation provided on January 30, 2026. The transition marks a significant change in the top leadership of the Adani-owned cement major.
Key Highlights
Mr. Ajay Kapur resigned as Managing Director effective January 31, 2026.
The resignation is due to superannuation (retirement) of the executive.
Formal resignation letter was filed with exchanges on February 03, 2026.
The move follows the company's prior regulatory disclosure dated January 30, 2026.
💼 Action for Investors
Investors should monitor the company's announcements regarding the appointment of a new Managing Director to ensure leadership continuity. While the retirement was planned, the strategic direction under new leadership will be a key factor for future performance.
ACE Q3 FY26 Results: Consolidated PAT Rises 4.2% YoY to ₹116.4 Cr, Revenue Dips 2.3%
Action Construction Equipment (ACE) reported a mixed performance for Q3 FY26, with consolidated revenue declining 2.3% YoY to ₹854.6 crore but showing a strong sequential recovery of 14.8% from Q2. Despite the slight YoY revenue dip, the company improved its profitability, with Consolidated PAT growing 4.2% YoY to ₹116.4 crore. The bottom line was supported by a significant reduction in finance costs, which fell 44.4% YoY to ₹4.67 crore. For the nine-month period, while revenue is down 4.9%, PAT remains resilient with a 4.6% growth, indicating improved operational efficiency.
Key Highlights
Consolidated Revenue from operations stood at ₹854.6 Cr, down 2.3% YoY but up 14.8% QoQ.
Consolidated Net Profit (PAT) increased to ₹116.4 Cr, a growth of 4.2% compared to ₹111.7 Cr in Q3 FY25.
Earnings Per Share (EPS) improved to ₹9.78 from ₹9.38 in the year-ago period.
Finance costs significantly reduced by 44.4% YoY to ₹4.67 Cr, aiding bottom-line growth.
Nine-month (9M FY26) Consolidated PAT grew to ₹304.2 Cr from ₹290.7 Cr in the previous year.
💼 Action for Investors
Investors should monitor if the sequential revenue growth continues into Q4, which is typically a strong quarter for construction equipment. While the YoY revenue stagnation is a concern, the company's ability to grow profits through cost control and lower debt is a positive sign.